<DOC>
	<DOCNO>NCT02408562</DOCNO>
	<brief_summary>This phase I , randomise , placebo-controlled study ass safety tolerability two 2-weeks cycle i.c.v . administration sNN0031 infusion solution patient PD moderate severity persist on-off symptom spite PD medication .</brief_summary>
	<brief_title>Study Tolerability Repeat i.c.v . Administration sNN0031 Infusion Solution Patients With PD</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Main 1 . Disease duration â‰¥ 5 year ( diagnosis base medical history neurological examination ) . 2 . Male female , age 30 75 year inclusive . 3 . Motor fluctuation , OFFtime &gt; 1.5 hour day 4 . A Hoehn Yahr stage 2 4 OFF phase 5 . Score &gt; 22 UPDRS part III ON phase 6 . Patients Ldopa responsive demonstrate least 30 % decrease UPDRS part III score administration Ldopa ( Ldopa challenge test ) 7 . Optimised stable antiParkinson treatment least 3 month screen Main 1 . The patient indication form parkinsonism idiopathic Parkinson 's disease 2 . The patient late stage Parkinson 's disease , experience severe , disable peakdose biphasic dyskinesia and/or unpredictable widely swing fluctuation symptom 3 . Patients treatment Duodopa Apomorphine pump time screen 4 . The patient implant shunt drainage CSF implanted Central Nervous System ( CNS ) catheter , receive neurosurgical intervention relate PD ( e.g . deep brain stimulation , thalamotomy etc . ) schedule trial period 5 . Concurrent diagnosis dementia score 24 low MiniMental State Examination ( MMSE ) . 6 . The patient depress , indicate Hamilton Depression Rating Scale ( GRIDHAMD , 17item scale ) score &gt; 17 7 . Patients high risk suicide judge rating Columbia Symptoms Suicide Rating Scale ( CSSRS ) 8 . Patients history increase intracranial pressure 9 . Ophthalmologic examination ( funduscopy visual acuity Early Treatment Diabetic Retinopathy Study ( EDTRS ) perimetry ) clinically significant finding imply safety concern study 10 . The patient current clinically significant gastrointestinal , renal , hepatic , endocrine , pulmonary cardiovascular disease 11 . The patient heart problem significant ECG abnormality 12 . Uncontrolled hypertension . 13 . The patient past experience psychotic symptom ( e.g . schizophrenia psychotic depression ) 14 . The patient mental physical condition would preclude perform study assessment 15 . Alcohol substance dependence within prior 12 month , abuse within 3 month , exception nicotine 16 . MRI examination finding tumours potential source pathological bleeding , abnormality may put patient risk 17 . History structural brain disease include tumour hyperplasia 18 . Ongoing suspect primary recurrent malignant disease ( currently active remission less one year ) 19 . Any disorder precludes surgical procedure , alters wind heal render chronic i.c.v . delivery device implant medically unsuitable 20 . The patient history current diagnosis HIV , Hepatitis B C. 21 . Increased susceptibility infection 22 . Women pregnant breast feed unwilling use adequate contraception trial ( woman child bear potential )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>